Orthofix Medical Inc. (NASDAQ:OFIX) Insider Lucas Vitale Sells 4,287 Shares

Orthofix Medical Inc. (NASDAQ:OFIX) insider Lucas Vitale sold 4,287 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total value of $71,164.20. Following the transaction, the insider now directly owns 135,317 shares in the company, valued at approximately $2,246,262.20. This represents a 3.07 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Orthofix Medical Price Performance

OFIX traded up $0.15 during trading on Thursday, reaching $16.90. The company’s stock had a trading volume of 265,196 shares, compared to its average volume of 255,080. The company has a quick ratio of 1.11, a current ratio of 2.39 and a debt-to-equity ratio of 0.25. The firm has a fifty day simple moving average of $17.79 and a two-hundred day simple moving average of $17.37. Orthofix Medical Inc. has a 1 year low of $12.08 and a 1 year high of $20.73. The company has a market cap of $659.47 million, a price-to-earnings ratio of -5.40 and a beta of 1.06.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on OFIX shares. Roth Mkm restated a “buy” rating and set a $22.00 target price on shares of Orthofix Medical in a report on Wednesday, February 26th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $24.00 price target on shares of Orthofix Medical in a research report on Wednesday, February 26th. Finally, StockNews.com raised shares of Orthofix Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $23.33.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of OFIX. Juniper Investment Company LLC lifted its stake in Orthofix Medical by 123.5% in the 4th quarter. Juniper Investment Company LLC now owns 1,937,249 shares of the medical device company’s stock worth $33,824,000 after purchasing an additional 1,070,656 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Orthofix Medical by 244.1% in the 4th quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company’s stock worth $5,070,000 after purchasing an additional 205,972 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Orthofix Medical by 31.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 659,475 shares of the medical device company’s stock worth $11,515,000 after purchasing an additional 159,177 shares in the last quarter. Emerald Mutual Fund Advisers Trust increased its holdings in shares of Orthofix Medical by 35.4% during the 4th quarter. Emerald Mutual Fund Advisers Trust now owns 503,802 shares of the medical device company’s stock worth $8,796,000 after buying an additional 131,653 shares during the last quarter. Finally, Boone Capital Management LLC increased its holdings in shares of Orthofix Medical by 13.6% during the 4th quarter. Boone Capital Management LLC now owns 1,057,313 shares of the medical device company’s stock worth $18,461,000 after buying an additional 126,806 shares during the last quarter. 89.76% of the stock is owned by hedge funds and other institutional investors.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.